4//SEC Filing
Kalled Susan 4
Accession 0000899243-21-018319
CIK 0001738021other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 3:03 PM ET
Size
5.4 KB
Accession
0000899243-21-018319
Insider Transaction Report
Form 4
Kalled Susan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-03+260,000→ 260,000 totalExercise: $7.00Exp: 2031-05-03→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]25% of this option vests on May 3, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001860504
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 3:03 PM ET
- Size
- 5.4 KB